BioCentury
ARTICLE | Financial News

Crinetics proposes $86.3M IPO

June 29, 2018 9:18 PM UTC

Endocrine disease company Crinetics Pharmaceuticals Inc. (San Diego, Calif.) proposed on June 22 to raise up to $86.3 million in an IPO on NASDAQ underwritten by J.P. Morgan, Leerink and Piper Jaffray.

In March, Crinetics raised a $63.5 million series B round led by Perceptive Advisors. The company’s largest shareholders are 5AM Ventures, Vivo Capital, Versant Ventures, Perceptive Advisors, OrbiMed Advisors and RA Capital (see “Perceptive leads Crinetics’ $63.5M series B”)...

BCIQ Company Profiles

Crinetics Pharmaceuticals Inc.